Buchang Pharmaceutical

Shandong Buchang Pharmaceutical Co., Ltd. is a large comprehensive private pharmaceutical group integrating drug R&D, production, and sales. It was established in May 2001, with its predecessor being Heze Pharmaceutical Factory. The registered capital is 612 million yuan, and the registered address is No. 369 Zhonghua West Road, Heze City, Shandong Province. Over the nine years since its establishment, adhering to the business philosophy of 'innovation as the soul' and guided by the principles of technology first and market orientation, the company has persisted in a path of technological innovation with Buchang characteristics, continuously accelerating corporate development and achieving gratifying results in production and operation. It has successively earned honors such as Shandong Province Traditional Chinese Medicine Modernization Demonstration Enterprise, Shandong Province High-tech Enterprise, Shandong Province Enterprise Technology Center, and National Comprehensive New Drug R&D Technology Platform (Shandong) Industrialization Demonstration Enterprise. Currently, the company holds 61 drug approval numbers and has 43 new drug varieties under research. Its production varieties cover ten categories of drugs and six dosage forms, including cardiovascular and cerebrovascular drugs, digestive system drugs, gynecological drugs, and cold remedies. Through independent R&D and technology transfer, it has obtained 22 invention patents, 3 appearance patents, and 14 invention patents under acceptance. The company's leading product, Wenxin Granules, according to the novelty search results from the Southern Medicine Economic Research Institute of the National Medical Products Administration, has ranked first for several consecutive years among oral antiarrhythmic traditional Chinese medicine preparations, accounting for a market share of 7.56%.